Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02701036 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sporadic Degenerative Ataxia With Adult Onset: Natural History Study

Study acronym: SPORTAX-NHS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 2 to 1
    • Secondary endpoints: 6 to 8
    v3
  2. Eligibility criteria expanded, about 6 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The key goals of SPORTAX-NHS is to compare the phenotype of multiple system atrophy of cerebellar type (MSA-C) and sporadic adult onset ataxia of unknown aetiology (SAOA) and to determine the rate of disease progression in both groups including determination of the factors that predict the development of MSA-C vs. SAOA, and at which time after onset of ataxia, a reliable distinction between both disorders is possible. The planned study will also allow to collect blood samples and other biomaterials from patients with sporadic ataxia, which will be useful for future genetic and biomarker studies.
Trial Details
NCT Number NCT02701036
Lead Sponsor Ataxia Study Group
Collaborators: German Center for Neurodegenerative Diseases (DZNE)
Conditions
(from sponsor)		 Late Onset Sporadic Cerebellar Ataxia
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov